Corbus Pharmaceuticals Holdings, Inc. (CRBP): $1.79

0.04 (+2.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRBP to Watchlist
Sign Up

Industry: Biotech


Ranked

of 491

in industry

Corbus Pharmaceuticals Holdings Inc (CRBP) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRBP.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $3 $1.22 $1.88 $1.64 14.63%

The Trend in the Analyst Price Target


CRBP's average price target has moved down $23.12 over the prior 273 days.

Over the past 273 days, CRBP's average upside potential has been 174.34%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-06-02 6 32 17.00 25.00 7.05 254.61%
2020-06-12 7 32 17.00 24.57 6.91 255.57%
2020-07-06 8 40 17.00 26.50 7.91 235.02%
2020-07-13 7 40 17.00 25.71 7.16 259.08%
2020-07-25 7 40 17.00 25.71 6.91 272.07%
2020-08-06 7 40 18.00 25.14 6.33 297.16%
2020-08-19 6 40 18.00 24.83 7.71 222.05%
2020-09-08 4 6 2.50 3.62 2.23 62.33%
2020-10-07 4 3 1.22 1.88 1.21 55.37%
2020-12-07 5 27 1.22 6.90 1.37 403.65%
2020-12-10 5 27 1.22 6.90 1.32 422.73%
2020-12-18 5 27 1.22 6.90 1.50 360%
2021-02-06 4 3 1.22 1.88 2.69 -30.11%
2021-02-13 4 3 1.22 1.88 2.99 -37.12%
2021-02-20 4 3 1.22 1.88 2.92 -35.62%
2021-02-27 4 3 1.22 1.88 2.18 -13.76%
2021-03-02 4 3 1.22 1.88 2.33 -19.31%

CRBP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.92 0 1 5 0 0 6

The Trend in the Broker Recommendations


CRBP's average broker recommendation rating worsened by 0.04 over the prior 30 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CRBP has a greater average analyst price target than 1.75% of all US stocks.
  • The variance in analysts' estimates of CRBP is less than 5.90000000000001% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of CRBP is greater than 12.74% of Pharmaceutical Products stocks.
  • CRBP has a higher number of analysts covering the stock than 34.55% of Pharmaceutical Products stocks.

Stocks similar to Corbus Pharmaceuticals Holdings Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LCI, APRE and IDRA.

Make investment decisions regarding CRBP using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7863 seconds.